Skip to content
GENIUS-CHD
GENIUS-CHD
Genetics of Subsequent Coronary Heart Disease
  • GENIUS-CHD
  • About
    • What is GENIUS-CHD?
    • Background & Rationale
  • Member Cohorts
  • Organisation
    • Scientific Steering Committee
    • Operational Committee
    • Project Specific Working Groups
  • Join Us
  • News
  • Documents
  • Contact

Contact Us

For all general enquiries, please contact us by email at:  genius.consortium@gmail.com

If you have any specific or scientific enquiries, please contact:

 

Dr. Riyaz Patel (UCL)

Email: riyaz.patel@ucl.ac.uk

 

Or

 

Prof. Folkert Asselbergs (UMCU)

Email: f.w.asselbergs@umcutrecht.nl

 

Contact us via email: genius.consortium@gmail.com

RSS Latest Articles on Subsequent CAD Risk Research

  • Proprotein convertase subtilisin/kexin type 9 inhibitor non responses in an adult with a history of coronary revascularization: A case report August 18, 2022
    CONCLUSION: Our outcome demonstrates that LDLR-W483X represents a partial loss-of-function LDLR and may contribute to PCSK9i ineffective. In the meanwhile, additional measures are therefore required (particularly with gene sequencing or change the treatment plan) must be initiated as early as possible. Genetic testing for clinically challenging cases who do not respond to PCSK9i therapy is […]
Copyright © 2022 GENIUS-CHD — Stout WordPress theme by GoDaddy